Treg Improved the Function of Human Amniotic Mesenchymal Stem Cell in Reducing Liver Cirrhosis Through Regulating Indoleamine 2,3-Dioxygenase Signaling. The gene discussed is IDO2; the disease is cirrhosis of liver.